过剩1
葡萄糖转运蛋白
生物
疾病
单倍率不足
神经科学
瓦博格效应
肿瘤微环境
主要促进者超家族
癌症研究
自噬
免疫系统
葡萄糖摄取
运输机
生物信息学
能源消耗
葡萄糖转运蛋白1型
糖酵解
医学
免疫失调
计算生物学
安普克
细胞生物学
作者
Yi Tai,Zhihao Chen,Y C Zhu,Weidong Han
出处
期刊:MedComm
[Wiley]
日期:2026-07-22
卷期号:7 (8): e70874-e70874
摘要
Glucose Transporter 1 (GLUT1) is the quintessential facilitator of basal glucose uptake, indispensable for maintaining cellular energy homeostasis, particularly across the blood-brain barrier. Beyond physiological necessity, GLUT1 dysregulation drives a broad pathological spectrum. While genetic haploinsufficiency precipitates severe neurological energy crises like Glut1 deficiency syndrome (Glut1DS), oncogenic networks hyperactivate GLUT1 as the central executor of the Warburg effect to fuel malignant proliferation. Despite its immense therapeutic potential, severe on-target toxicity in normal tissues and adaptive metabolic plasticity remain critical roadblocks to systemic GLUT1 inhibition. This review comprehensively synthesizes GLUT1's multidimensional regulatory networks in health and disease, dissecting how its overexpression fundamentally remodels the tumor microenvironment (TME). We elucidate how GLUT1-driven "metabolic competition" fosters metabolic immune exclusion and drives therapeutic resistance. Furthermore, we map the paradigm shift from traditional systemic blockades to emerging precision interventions. Specifically, we highlight "Trojan horse" glycan-functionalized nanocarriers, targeted protein degradation technologies like PROTACs, and metabolically engineered CAR-T cells. By conceptualizing GLUT1 as the linchpin of the immunosuppressive ecosystem, this work provides a strategic roadmap for precision metabolic immuno-oncology, guiding the development of novel therapies that maximize durable efficacy while minimizing collateral physiological damage.
科研通智能强力驱动
Strongly Powered by AbleSci AI